Irvine-based Masimo Corp. today announced that its proposed $9.9 billion acquisition by Danaher Corp. has been approved by shareholders.
“We thank our shareholders for their strong support of this important milestone for Masimo,” Chief Executive Katie Szyman said in a statement.
The proposed acquisition, first announced in February, passed with 36,981,681 votes in favor, 17,061 against and 14,035 abstentions at a special meeting held on May 1, according to an 8-K filing.
Upon the deal closing, Masimo will become a standalone business unit and brand within Washington-based Danaher’s diagnostic segment. Masimo said that it expects the deal to close some time this year.
Shares in Masimo were little changed at $178.26 and a $9.3 billion market cap following the announcement (Nasdaq: MASI).
